This announcement just proves the superiority of design and tissue, other companies had to do animal trials for 2 years+ on pigs, sheep and cows before proceeding ahead with human trials.
For Admedus, to have a leading specialist recommend human trials after only having the SAVR implanted in sheep shows beyond doubt that the company has come up with a great revolutionary product that will benefit many heart patients and grow the company.
Ann: SAVR Clinical Trial, page-9
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.00 |
Change
0.000(0.00%) |
Mkt cap ! $253.6M | |||
| Open | High | Low | Value | Volume |
| $11.88 | $12.00 | $11.50 | $261.8K | 22.14K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 156 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.00 | 6045 | 3 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |